Pulmonx Corporation (LUNG)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-07-29) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-04-29) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-04) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-12) · 99.1 | 8-K (2025-10-27) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-07-30) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-04-30) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-19) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-10-30) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-07-31) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-01) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-21) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-10-30) · 99.1 | 8-K (2023-10-10) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Stockholders Equity | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Balance Sheet Components | ||
| Commitments and Contingencies | — |
|
| Common Stock Warrant Liability | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Employee Benefit Plan | — |
|
| Fair Value Measurements | ||
| Formation and Business of The Company | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases, Lease Commitments and Contingencies | — |
|
| Long Term Debt | ||
| Net Loss Per Share Attributable To Common Stockholders | ||
| Pay Vs Performance Disclosure | ||
| Recent Accounting Pronouncements | ||
| Revenue | — |
|
| Revenue Recognition | ||
| Segment Information | ||
| Stockholders' Equity | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||